Evidence map›Paper›PMID 42244012›Full record

ArticleJournal of cardiothoracic surgery2026

Natural history of aortic valve disease after rheumatic mitral valve surgery: implications for concomitant aortic intervention.

Hamideh Khesali, Sara Shemshadi, Pourya Kanani, Fateme Yousefimoghaddam, Yaghoob Bagheri, Soheila Salari

Abstract read
In one paragraph

Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hamideh KhesaliHeart Valve Disease Research Center, Rajaie Cardiovascular Institute, Tehran, Iran.
Sara ShemshadiEchocardiography Research Center, Rajaie Cardiovascular Institute, Tehran, Iran.
Pourya KananiHeart Valve Disease Research Center, Rajaie Cardiovascular Institute, Tehran, Iran.
Fateme YousefimoghaddamHeart Valve Disease Research Center, Rajaie Cardiovascular Institute, Tehran, Iran.
Yaghoob BagheriHeart Valve Disease Research Center, Rajaie Cardiovascular Institute, Tehran, Iran.
Soheila SalariCongenital Heart Diseases Research Center, Rajaie Cardiovascular Institute, Tehran, Iran. salarimed@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRheumatic heart disease (RHD) frequently affects both mitral and aortic valves. While mitral valve replacement (MVR) is often prioritized, the natural history of coexisting aortic valve disease particularly when mild or moderate is less well understood.

objectiveThe objective of this study is to assess the progression of aortic stenosis (AS) and aortic insufficiency (AI) in patients undergoing isolated MVR for rheumatic mitral disease.

methodsWe conducted a single-center retrospective cohort study involving 403 adult patients with rheumatic mitral valve disease who underwent isolated MVR at Rajaie Cardiovascular Medical and Research Center between 2010 and 2022. Patients with a history of aortic valve replacement or early postoperative mortality (defined as death within 30 days of surgery) were excluded. Serial transthoracic echocardiography was performed at baseline, 3 months postoperatively, and annually thereafter, with a mean follow-up duration of 78 months. We evaluated baseline and longitudinal changes in the severity of aortic stenosis (AS) and aortic insufficiency (AI), as well as alterations in left ventricular function and pulmonary artery pressures over time. The severity of aortic valve disease was classified according to the American Heart Association (AHA) 2020 and European Society of Cardiology (ESC) 2025 guidelines.

resultsAt baseline, 9.2% had AS (6.2% mild, 3.0% moderate) and 67% had AI (57.6% mild, 9.4% moderate). During our follow up among patients with mild AS, we observed sever AS is 20% progressing to severe AS, compared with 41.7% progressing to moderate AS. For AI, we observed 3.0% progression to severe AI for patients with mild baseline disease and is 7.8% for patients with moderate baseline disease. Baseline aortic valve lesion severity independently predicted progression (HR 4.2, 95% CI 1.9-9.1, p < 0.001). No other clinical or echocardiographic parameters were significant. Survival analysis showed higher cumulative progression rates among those with baseline lesions (p < 0.001).

conclusionsBaseline aortic valve involvement predicts subsequent deterioration after MVR. Routine prophylactic AVR is not supported for mild AI, but moderate AS warrants closer follow-up and individualized surgical consideration. Larger, prospective studies are needed to refine risk prediction for concomitant aortic intervention.

Indexed as

Aortic Valve DiseaseAortic Valve InsufficiencyAortic Valve StenosisHeart Valve Prosthesis ImplantationMitral ValveRheumatic Heart DiseaseAdultDisease ProgressionEchocardiographyFemaleFollow-Up StudiesHumansMaleMiddle AgedRetrospective StudiesAortic Stenosis, Aortic InsufficiencyAortic valve diseaseDisease progressionMitral valve replacementRheumatic heart disease

Identifiers

PMID42244012
PMCPMC13459377

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.